Correction: Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals

Oncotarget. 2021 Jan 5;12(1):61-62. doi: 10.18632/oncotarget.27638.

Pengjun Zhou^#^{1

2}, Rong Zhang^#³, Ying Wang¹, Dandan Xu⁴, Li Zhang⁵, Jinhong Qin¹, Guifeng Su¹, Yue Feng¹, Hongce Chen², Siyuan You², Wen Rui², Huizhong Liu⁶, Suhong Chen⁴, Hongyuan Chen^{2

7}, Yifei Wang¹

¹ Guangzhou Jinan Biomedicine Research and Development Center, Guangdong Provincial Key Laboratory of Bioengineering Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, Guangdong, P. R. China.
² Department of Pathogen Biology and Immunology, School of Basic Course, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, P. R. China.
³ State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, Guangdong, P. R. China.
⁴ Guangdong Food and Drug Vocational College, Guangzhou 510520, Guangdong, P. R. China.
⁵ Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, P. R. China.
⁶ Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shanxi, P. R. China.
⁷ Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, P. R. China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.22676.].